Biocryst pharmaceuticals drug approved for sale in europe
BCRX's Drug (Orladeyo) was recently approved by the european commission for sale in europe :European Approval document: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/orladeyo-0
wiki page on the drug: https://en.wikipedia.org/wiki/Berotralstat
This was previously only available in the US via prescription.
Access to additional markets should be healthy for the companies' balance sheet.
My plan:
Short term:
Change in sentiment is a good short term trade:
Short term play:
Bull debit option spread:
long May 21st $12 CALL
Short May 21st $15 CALL
Long term play:
Buy and hold 100 shares, sell 45 DTE covered calls against these shares, planning to hold for a period of 2-4 years if my outlook remains bullish .
I will review earnings calls, cash flows and balance sheets and review my sentiment after each quarter.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.